CytomX Therapeutics, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2015 | 97.51x | $0.21 | $20.87 |
| Dec 2016 | 26.66x | $0.41 | $10.99 |
| Dec 2017 | 11.34x | $1.86 | $21.11 |
| Dec 2018 | 11.44x | $1.32 | $15.10 |
| Dec 2019 | 6.58x | $1.26 | $8.31 |
| Dec 2020 | 3.35x | $1.95 | $6.55 |
| Mar 2021 | 4.60x | $0.94 | $4.33 |
| Jun 2021 | 4.93x | $0.88 | $4.33 |
| Sep 2021 | 4.96x | $0.87 | $4.33 |
| Dec 2021 | 4.64x | $0.93 | $4.33 |
| Mar 2022 | 1.94x | $0.83 | $1.60 |
| Jun 2022 | 2.07x | $0.77 | $1.60 |
| Sep 2022 | 2.39x | $0.67 | $1.60 |
| Dec 2022 | 1.98x | $0.81 | $1.60 |
| Dec 2023 | 1.13x | $1.37 | $1.55 |
| Dec 2024 | 0.63x | $1.63 | $1.03 |
| Dec 2025 | 7.53x | $0.55 | $4.16 |